NAPLEX Respiratory Pharmacology Practice Questions with Answers

Concept Explanation

NAPLEX respiratory pharmacology encompasses the clinical management of obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) through the strategic use of bronchodilators, anti-inflammatory agents, and leukotriene modifiers. Understanding these drug classes is essential for optimizing patient outcomes in respiratory care, as outlined by the National Heart, Lung, and Blood Institute (NHLBI) guidelines.

Respiratory pharmacotherapy primarily focuses on two mechanisms: achieving bronchodilation to facilitate airflow and reducing airway inflammation to prevent exacerbations. Key drug classes include:

• Beta-2 Agonists: Short-acting (SABA) like albuterol for rescue, and long-acting (LABA) like salmeterol for maintenance.
• Inhaled Corticosteroids (ICS): The cornerstone of long-term asthma control, such as fluticasone or budesonide.
• Muscarinic Antagonists: Short-acting (SAMA) like ipratropium and long-acting (LAMA) like tiotropium, commonly used in COPD.
• Leukotriene Receptor Antagonists (LTRAs): Montelukast, which serves as an alternative for mild persistent asthma.

For those preparing for the board exam, mastering these concepts is a critical component of NAPLEX Prep. Integrating these drug classes with patient-specific factors—such as age, severity of disease, and inhaler technique—is vital for passing the exam.

Solved Examples

1. Question: A patient is currently prescribed salmeterol monotherapy for persistent asthma. What is the primary clinical concern with this treatment plan?
   Solution: The primary concern is the increased risk of asthma-related death when LABAs are used without an inhaled corticosteroid. According to the FDA, LABAs should never be used as monotherapy for asthma management.
2. Question: Calculate the total dosage of albuterol delivered if a patient uses two puffs from a HFA inhaler (90 mcg/puff) four times daily.
   Solution: $$2 \ \text{ puffs} \ \times 90 \ \text{ mcg/puff} = 180 \ \text{ mcg per dose}$$ $$180 \ \text{ mcg/dose} \ \times 4 \ \text{ doses/day} = 720 \ \text{ mcg/day}$$
3. Question: Which counseling point is essential for a patient starting fluticasone/salmeterol (Advair Diskus)?
   Solution: The patient must rinse their mouth with water and spit after each use to prevent oral candidiasis (thrush), a common side effect of inhaled corticosteroids.

Practice Questions

1. A patient with COPD presents with persistent dyspnea despite using albuterol PRN. Which of the following is the most appropriate next step in therapy according to GOLD guidelines?
   a) Add a LAMA
   b) Add a systemic corticosteroid
   c) Add montelukast
   d) Switch to a SAMA
2. Which of the following medications is classified as an LTRA and carries a warning for neuropsychiatric events?
   a) Zafirlukast
   b) Montelukast
   c) Theophylline
   d) Omalizumab
3. The pharmacist is counseling a patient on the use of a dry powder inhaler (DPI). Which instruction is correct?
   a) Shake the inhaler vigorously before use.
   b) Use a spacer device to improve drug delivery.
   c) Inhale deeply and quickly to ensure the powder reaches the lungs.
   d) Prime the inhaler by spraying into the air before the first use.

4. Which agent is a phosphodiesterase-4 inhibitor used specifically to reduce the risk of COPD exacerbations?
   a) Roflumilast
   b) Theophylline
   c) Indacaterol
   d) Umeclidinium
5. A patient is using tiotropium (Spiriva HandiHaler). How should the capsule be administered?
   a) Swallowed whole with water.
   b) Placed into the device, pierced, and inhaled.
   c) Dissolved in a nebulizer solution.
   d) Used as a sublingual tablet.
6. Which of the following is a classic side effect of systemic corticosteroids used during an acute exacerbation?
   a) Hypoglycemia
   b) Hyperkalemia
   c) Hyperglycemia
   d) Hypotension
7. What is the therapeutic range for theophylline?
   a) 5-15 mcg/mL
   b) 10-20 mcg/mL
   c) 20-30 mcg/mL
   d) 5-20 mcg/mL
8. Which inhaler requires priming before use?
   a) Advair Diskus
   b) ProAir HFA
   c) Symbicort Turbuhaler
   d) Flovent Diskus

Answers & Explanations

1. Answer: a) Add a LAMA. GOLD guidelines recommend adding a long-acting muscarinic antagonist (LAMA) for patients with COPD who continue to have symptoms on SABA monotherapy.
2. Answer: b) Montelukast. Montelukast is an LTRA that carries an FDA boxed warning regarding serious neuropsychiatric events, including agitation and depression.
3. Answer: c) Inhale deeply and quickly. Unlike MDIs, DPIs rely on the patient's inspiratory effort to pull the powder into the lungs; therefore, a deep, rapid breath is required.
4. Answer: a) Roflumilast. Roflumilast is a PDE-4 inhibitor that increases cAMP levels, reducing inflammation and exacerbations in severe COPD.
5. Answer: b) Placed into the device, pierced, and inhaled. The HandiHaler is a specific DPI device where the capsule is loaded and pierced so the medication can be inhaled.
6. Answer: c) Hyperglycemia. Systemic steroids increase glucose production, often leading to elevated blood glucose levels, even in non-diabetic patients.
7. Answer: a) 5-15 mcg/mL. The therapeutic range for theophylline is narrow, typically 5-15 mcg/mL, requiring careful monitoring to avoid toxicity.
8. Answer: b) ProAir HFA. Metered-dose inhalers (MDIs) like ProAir HFA require priming if the inhaler has not been used for a certain period, whereas DPIs usually do not.

Quick Quiz

Frequently Asked Questions

Why are LABAs not used as monotherapy in asthma?

LABAs used alone in asthma can mask worsening inflammation while providing temporary bronchodilation, leading to an increased risk of severe, life-threatening asthma exacerbations or death. Current clinical guidelines mandate that they be used only in combination with an inhaled corticosteroid.

What is the difference between an MDI and a DPI?

An MDI (Metered-Dose Inhaler) uses a propellant to deliver a medication spray and often requires a slow, deep inhalation. A DPI (Dry Powder Inhaler) contains medication in powder form and relies on the patient's own forceful, rapid inhalation to pull the medication into the airways.

How do I manage a patient who cannot coordinate MDI usage?

For patients who struggle with the hand-breath coordination required for MDIs, the most effective solution is to add a valved holding chamber or spacer device. If the patient still cannot use the device correctly, consider switching to a DPI or a nebulizer solution.

Are there specific monitoring requirements for Roflumilast?

Roflumilast is associated with weight loss and psychiatric side effects, so patients should have their weight monitored regularly. It is also contraindicated in patients with moderate to severe hepatic impairment due to increased drug exposure.

When should a patient use their rescue inhaler?

A rescue inhaler, such as albuterol, should be used for the immediate relief of acute symptoms like wheezing, shortness of breath, or chest tightness. If a patient requires their rescue inhaler more than twice a week, it indicates that their asthma is not well-controlled and requires a step-up in maintenance therapy.

Tags

Enjoyed this article?

Share it with others who might find it helpful.

Share Article